Barclays Has Lowered Expectations for Exact Sciences (NASDAQ:EXAS) Stock Price
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price target dropped by stock analysts at Barclays from $75.00 to $65.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical research company’s stock. Barclays‘s price objective would indicate a potential upside of 25.19% from the company’s […]
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price target dropped by stock analysts at Barclays from $75.00 to $65.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical research company’s stock. Barclays‘s price objective would indicate a potential upside of 25.19% from the company’s […]
